8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)   April 25, 2007

INTRICON CORPORATION

(Exact name of registrant as specified in its charter)

Pennsylvania	1-5005	23-1069060
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

1260 Red Fox Road, Arden Hills, MN 55112

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (651) 636-9770

____________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition

The following information is being provided pursuant to Item 2.02. Such information, including the exhibit attached hereto, should not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

On April 25, 2007, IntriCon Corporation announced earnings for the quarter ended March 31, 2007. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure

The following information is being provided pursuant to Item 7.01. Such information, including the exhibit attached hereto, should not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

The information contained under Item 2.02 is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release April 25, 2007.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	IntriCon Corporation
	By:	/s/Scott Longval
Date:   May 1, 2007		Scott Longval Chief Financial Officer

Exhibit Index

99.1 Press Release dated April 25, 2007

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

INTRICON REPORTS 2007 FIRST-QUARTER RESULTS

Strong Sales Driven by 138 Percent Growth in Medical

and Robust Hearing-health Performance

ST. PAUL, Minn. — April 25, 2007 — IntriCon Corporation (AMEX: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature medical and electronics products, today announced financial results for its 2007 first quarter ended March 31, 2007.

For the first quarter, the company reported sales of $14.6 million, a 23 percent increase from sales of $11.8 million for the 2006 first quarter. IntriCon delivered first-quarter net income of $28,000, or $0.01 per diluted share, which included stock option expense of $73,000, or $0.01 per diluted share. This is a significant improvement from a net loss of $141,000, or $0.03 per diluted share, for the 2006 first quarter, which included stock option expense of $44,000, or $0.01 per diluted share.

“Substantial gains in our medical and hearing-health businesses helped deliver strong quarterly sales,” said Mark S. Gorder, president and chief executive officer of IntriCon. “High demand from leading OEMs combined with the ramp-up of new projects drove the increase. We are very pleased with the great start to 2007.”

Business Update

For the first quarter,IntriCon’s 23 percent sales increase was driven primarily by year-over-year gains in medical and hearing-health of approximately 138 percent and 13 percent, respectively. Professional audio declined by 5 percent due to project timing; new professional audio projects are expected to gain traction in the current quarter. Electronics decreased 8 percent from the first quarter of 2006, due primary to lower demand from one customer.

Said Gorder, “Excluding electronics, revenue from the company’s core businesses of medical, hearing-health and professional audio were up a combined 32 percent from the fiscal 2006 first quarter. Going forward, we plan to further develop our existing relationships with major medical OEMs, as well as forge new relationships, to continue to grow this rapidly expanding market opportunity.”

(more)

IntriCon Corporation 2007 First-Quarter Results

April 25, 2007

Page 2

Recently, IntriCon entered into an agreement to acquire substantially all of the assets (other than real estate) of privately held Tibbetts Industries, Inc., a designer and manufacturer of components used in hearing aids and medical devices. Tibbetts, based in Camden, Maine, makes magnetic telecoils and miniature electro-acoustic transducers, including receivers and microphones. Tibbetts also offers products that support technical surveillance by security agencies. The acquisition is expected to be completed in May 2007, subject to Tibbetts’ shareholder approval and other customary closing conditions.

Said Gorder, “Our acquisition of Tibbetts gives IntriCon access to key components that go into ear-worn communication devices used in hearing health, medical and professional audio products such as hearing aids, and ear-worn headsets and microphones. With IntriCon’s established wireless and digital signal processing expertise, and the new markets and opportunities this transaction brings, we feel that we can leverage Tibbetts’ expertise, technologies and products across our three core markets to further grow IntriCon.”

Concluded Gorder, “We’re beginning 2007 with momentum in both sales and new-product introductions. By focusing on our core markets, which continue to perform well, we expect to achieve ongoing success as we move forward.”

About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature medical and electronic products. The company is focused on four key markets: medical, hearing health, professional audio and communications, and electronics. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the American Stock Exchange. For more information about IntriCon, visit www.intricon.com.

(more)

IntriCon Corporation 2007 First-Quarter Results

April 25, 2007

Page 3

Forward-Looking Statements

Statements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology such as “may”, “will”, “believe”, “expect”, “should”, “optimistic” or “continue” or the negative thereof or other variations thereon are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934 as amended. These forward-looking statements include, without limitation, statements concerning the proposed acquisition and its benefits, future growth, future financial condition and performance, prospects, and the positioning of IntriCon to compete in chosen markets. These forward-looking statements are affected by known and unknown risks, uncertainties and other factors that are beyond the IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and factors include, without limitation, the risk that the planned acquisition may not close on the terms agreed upon or at all, risks related to the acquisition, including unanticipated liabilities and expenses, the risk that IntriCon may not be able to achieve its long-term strategy, weakening demand for products of the company due to general economic conditions, possible non-performance of developing technological products, the volume and timing of orders received by the company, changes in the mix of products sold, competitive pricing pressures, availability of electronic components for the company’s products, ability to create and market products in a timely manner, competition by competitors with more resources than the company, foreign currency risks arising from the company’s foreign operations and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2006. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.

Contacts
At IntriCon: Scott Longval, CFO 651-604-9526 slongval@intricon.com	At Padilla Speer Beardsley: Matt Sullivan/Marian Briggs 612-455-1700 msullivan@psbpr.com / mbriggs@psbpr.com

(more)

IntriCon Corporation 2007 First-Quarter Results

April 25, 2007

Page 4

IntriCon Corporation

Consolidated Condensed Statements of Operations

(Unaudited)

	Three Months Ended
	March 31, 2007			March 31, 2006
Sales, net	$	14,579,267		$	11,836,133
Costs of sales		11,368,010			9,069,723
Gross profit		3,211,257			2,766,410
Operating expenses:
Selling expense		842,766			902,421
General and administrative expense (a)		1,420,264			1,305,409
Research and development expense		732,681			568,983
Total operating expenses		2,995,711			2,776,813
Operating income (loss)		215,546			(10,403	)
Interest expense		(153,277	)		(156,527	)
Interest income		38,736			21,893
Equity in loss of partnership		(20,000	)		—
Other expense, net		(25,737	)		(34,285	)
Income (loss) before income taxes		55,268			(179,322	)
Income tax expense (benefit)		27,760			(37,913	)
Net income (loss)	$	27,508		$	(141,409	)
Earnings per share:
Basic and diluted	$	.01		$	(.03	)
Average shares outstanding:
Basic		5,196,903			5,151,942
Diluted		5,358,986			5,151,942

(a) General and administrative expense includes $73,073 and $44,261 of non-cash stock option expense related to the adoption of FAS 123(R) for the three months ended March 31, 2007 and 2006, respectively.

(more)

IntriCon Corporation 2007 First-Quarter Results

April 25, 2007

Page 5

IntriCon Corporation

Consolidated Condensed Balance Sheets

(Unaudited)

Assets
	March 31, 2007		December 31, 2006
	(unaudited)
Current assets
Cash	$	743,794	$	599,459
Restricted cash		60,158		60,158
Accounts receivable, less allowance for doubtful accounts of $216,000 at 2007 and $246,000 at 2006		7,759,799		8,456,450
Inventories		9,677,273		9,030,615
Refundable income taxes		74,338		103,587
Note receivable from sale of discontinued operations, less allowance of $375,000 at 2007 and 2006		300,000		300,000
Other current assets		226,511		235,418
Total current assets		18,841,873		18,785,687
Property, plant and equipment
Machinery and equipment		29,532,592		28,767,904
Less: accumulated depreciation		22,440,337		21,994,344
Net property, plant and equipment		7,092,255		6,773,560
Long-term note receivable from sale of discontinued operations		—		75,000
Goodwill		5,927,181		5,927,181
Investment in partnership		1,780,000		1,800,000
Other assets, net		959,917		920,051
	$	34,601,226	$	34,281,479

(more)

IntriCon Corporation 2007 First-Quarter Results

April 25, 2007

Page 6

IntriCon Corporation

Consolidated Condensed Balance Sheets

(Unaudited)

Liabilities and Shareholders’ Equity	March 31, 2007			December 31, 2006
	(unaudited)
Current liabilities
Checks written in excess of cash	$	1,349,563		$	661,756
Current maturities of long-term debt		1,137,271			952,730
Accounts payable		3,658,739			5,161,450
Income taxes payable		179,022			173,810
Deferred gain on building sale		110,084			110,084
Short term partnership payable		260,000			260,000
Other accrued liabilities		2,844,178			3,021,201
Total current liabilities		9,538,857			10,341,031
Long term debt, less current maturities		4,903,963			3,830,461
Other post-retirement benefit obligations		1,036,331			1,063,744
Long term partnership payable		1,280,000			1,280,000
Note payable, net of current portion (Amecon)		515,720			515,720
Deferred income taxes		79,273			79,273
Accrued pension liability		616,829			628,569
Deferred gain on building sale		908,194			935,715
Total non-current liabilities		9,340,310			8,333,482
Total liabilities		18,879,167			18,674,513
Commitments and contingencies
Shareholders’ equity
Common shares, $1 par; 10,000,000 shares authorized; 5,710,235 and 5,706,235 shares issued; 5,194,481 and 5,190,481 outstanding		5,710,235			5,706,235
Additional paid-in capital		12,417,561			12,339,988
Accumulated deficit		(961,997	)		(989,505	)
Accumulated other comprehensive loss		(178,662	)		(184,674	)
Less: 515,754 common shares held in treasury, at cost		(1,265,078	)		(1,265,078	)
Total shareholders’ equity		15,722,059			15,606,966
	$	34,601,226		$	34,281,479

###